Prescribing Information for ▼PAXLOVID (nirmatrelvir / ritonavir) can be found here: Great Britain and Northern Ireland. Adverse event reporting information can be found at the bottom of the page. Please note, there are differences between the SmPC for Northern Ireland and the SmPC for Great Britain. Please refer to the appropriate SmPC depending on where you are based.
Paxlovid has a Conditional Marketing Authorisation in Great Britain. A Conditional Marketing Authorisation means that further evidence on this medicinal product is awaited. New information on this medicinal product will be reviewed when any relevant information of significance becomes available and at least every year and the product information will be updated as necessary.
Great Britain
Northern Ireland
For HCPs
Eligible High Risk Cohorts One Pager
A one page summary of the high risk adult patients who are eligible for COVID-19 treatment.
Download
For HCPs
Optimising the COVID-19 Treatment Pathway Case Study
An interactive resource to support the development of Sustainable, Efficient, Accessible and Scalable COVID-19 treatment services.
Download
For HCPs
Mechanism of Action Flashcard
A digital flashcard providing educational information about the Paxlovid Mechanism of Action.
Download
For HCPs
Patient Case Study: Reducing Health Inequalities
A two-page case study on identifying and educating patients at high risk of severe COVID-19 progression at Stonyhill Medical Practice in Blackpool.
Download
For HCPs
Eligible High Risk Cohorts One Pager
A one page summary of the high risk adult patients who are eligible for COVID-19
Download
For HCPs
Patient Case Study: Reducing Health Inequalities
A two-page case study on identifying and educating patients at high risk of severe COVID-19 progression at Stonyhill Medical Practice in Blackpool.
Download
For HCPs
PAXLOVID Dosing Guide
A guide for NI healthcare professionals highlighting dosing information for PAXLOVID.
Download
For HCPs
Optimising the COVID-19 Treatment Pathway Case Study
An interactive resource to support the development of Sustainable, Efficient, Accessible and Scalable COVID-19 treatment services.
Download
PAXLOVID contains nirmatrelvir, a protease inhibitor designed to target the main SARS-CoV-2 protease and inhibit replication by preventing proteolysis from occurring.1,2
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024